骨髓移植市場：按類型、治療類型、最終用戶分類 - 全球預測 2023-2030

全球骨髓移植市場預計將大幅成長，2023年將達到162.7億美元，年複合成長率為8.67%，2030年將達到292.6億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球骨髓移植市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的具體需求做出明智的資訊。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.全球骨髓移植市場規模及預測是多少？

2.在預測期內，COVID-19對全球骨髓移植市場的抑制要素和影響有哪些？

3.在預測期內，全球骨髓移植市場需要投資哪些產品/細分市場/應用/領域？

4.全球骨髓移植市場的競爭策略是什麼？

5. 全球骨髓移植市場的技術趨勢和法律規範是什麼？

6.全球骨髓移植市場主要廠商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球骨髓移植市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 增加血癌的患病率和骨髓移植的可及性
    • 細胞治療和組織工程產品的商業化程度提高
    • 政府努力提高治療意識
  • 抑制因素
    • 治療費用昂貴且無賠償
  • 機會
    • 骨髓移植治療的技術進步
    • BMT 正在進行的研發活動
  • 課題
    • 對 GVHD、感染疾病和復發的擔憂
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通貨膨脹的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 骨髓移植市場：按類型

• 同種異體移植
• 自體移植

第7章 按治療類型分類的骨髓移植市場

• 再生障礙性貧血
• 白血病
• 淋巴瘤
• 骨髓發育不良症候群
• 骨髓瘤
• 骨髓增生性疾病
• 鐮狀細胞性貧血
• 實體瘤
• 地中海貧血

第8章 骨髓移植市場：按最終用戶分類

• 門診手術中心
• 醫院
• 多專科診所

第9章 美洲骨髓移植市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太骨髓移植市場

• 澳大利亞
• 中國
• 印度
• 印度尼西亞
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲骨髓移植市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市場佔有率分析：主要企業
• 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可和定價

The Global Bone Marrow Transplantation Market is forecasted to grow significantly, with a projected USD 16.27 billion in 2023 at a CAGR of 8.67% and expected to reach a staggering USD 29.26 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Bone Marrow Transplantation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Bone Marrow Transplantation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across Allogeneic Transplant and Autologous Transplant. The Allogeneic Transplant is projected to witness significant market share during forecast period.

Based on Treatment Type, market is studied across Aplastic Anemia, Leukemia, Lymphoma, Myelodysplastic Syndrome, Myeloma, Myeloproliferative Disorders, Sickle cell Anemia, Solid Tumors, and Thalassemia. The Lymphoma is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Multi-Specialty Clinics. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Bone Marrow Transplantation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Bone Marrow Transplantation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Bone Marrow Transplantation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Bone Marrow Transplantation Market?

4. What is the competitive strategic window for opportunities in the Global Bone Marrow Transplantation Market?

5. What are the technology trends and regulatory frameworks in the Global Bone Marrow Transplantation Market?

6. What is the market share of the leading vendors in the Global Bone Marrow Transplantation Market?

7. What modes and strategic moves are considered suitable for entering the Global Bone Marrow Transplantation Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Bone Marrow Transplantation Market, by Type, 2022 vs 2030
• 4.3. Bone Marrow Transplantation Market, by Treatment Type, 2022 vs 2030
• 4.4. Bone Marrow Transplantation Market, by End-User, 2022 vs 2030
• 4.5. Bone Marrow Transplantation Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of blood cancer and improving accessibility to bone marrow transplantation
    • 5.1.1.2. Increased commercialization of cell therapy and tissue engineering products
    • 5.1.1.3. Government initiatives to improve awareness of the therapy
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the treatment and lack of reimbursement
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in bone marrow transplantation therapy
    • 5.1.3.2. Ongoing research & development activities of BMT
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns related to GVHD, infections and relapse
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Bone Marrow Transplantation Market, by Type

• 6.1. Introduction
• 6.2. Allogeneic Transplant
• 6.3. Autologous Transplant

7. Bone Marrow Transplantation Market, by Treatment Type

• 7.1. Introduction
• 7.2. Aplastic Anemia
• 7.3. Leukemia
• 7.4. Lymphoma
• 7.5. Myelodysplastic Syndrome
• 7.6. Myeloma
• 7.7. Myeloproliferative Disorders
• 7.8. Sickle cell Anemia
• 7.9. Solid Tumors
• 7.10. Thalassemia

8. Bone Marrow Transplantation Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals
• 8.4. Multi-Specialty Clinics

9. Americas Bone Marrow Transplantation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bone Marrow Transplantation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bone Marrow Transplantation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. BONE MARROW TRANSPLANTATION MARKET RESEARCH PROCESS
• FIGURE 2. BONE MARROW TRANSPLANTATION MARKET SIZE, 2022 VS 2030
• FIGURE 3. BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2030 (%)
• FIGURE 6. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. BONE MARROW TRANSPLANTATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. BONE MARROW TRANSPLANTATION MARKET DYNAMICS
• FIGURE 9. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. BONE MARROW TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. BONE MARROW TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. BONE MARROW TRANSPLANTATION MARKET SIZE, BY ALLOGENEIC TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. BONE MARROW TRANSPLANTATION MARKET SIZE, BY AUTOLOGOUS TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. BONE MARROW TRANSPLANTATION MARKET SIZE, BY APLASTIC ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. BONE MARROW TRANSPLANTATION MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. BONE MARROW TRANSPLANTATION MARKET SIZE, BY LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELODYSPLASTIC SYNDROME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. BONE MARROW TRANSPLANTATION MARKET SIZE, BY MYELOPROLIFERATIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. BONE MARROW TRANSPLANTATION MARKET SIZE, BY SICKLE CELL ANEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. BONE MARROW TRANSPLANTATION MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. BONE MARROW TRANSPLANTATION MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 18. BONE MARROW TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. BONE MARROW TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. BONE MARROW TRANSPLANTATION MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. CHINA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. ITALY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. POLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. QATAR BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM BONE MARROW TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. BONE MARROW TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 149. BONE MARROW TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 150. BONE MARROW TRANSPLANTATION MARKET LICENSE & PRICING